Leishmaniasis is endemic in tropical regions and currently affects 12 million people in 88 countries. 6) The disease is transmitted by small biting sandflies (Phlebotomus spp.). The first-line drugs for the treatment of leishmaniasis are pentavalent antimonials such as N-methylglucamine antimonate (Glucantime ® ) and sodium stilbogluconate (Pentostam   ®   ) . However, these drugs are toxic and generally expensive. Therefore, we have been searching for new medicines from plant sources that grow in areas where leishmaniasis is distributed. We have already reported several leishmanicidal constituents of medicinal plants in tropical and subtropical regions (Peru, Myanmar, Bolivia, Pakistan, etc.). [7] [8] [9] [10] [11] In the first screening of hundreds of Peruvian medicinal plant extracts for leishmanicidal activity, we found that the extract of Bocconia pearcei fruit exhibited potent activity.
In this paper, we describe the chemical components of 'Yanali' and their leishmanicidal activities in vitro and the structure-activity relationships using several derivatives of benzophenanthridine alkaloids.
Results and Discussion
The methanolic extract of B. pearcei fruit exhibited the most potent leishmanicidal activity in vitro [Minimum Lethal Concentration (MLC): 3.1 mg/ml] in a screening with hundreds of Peruvian plant extracts. Therefore, we investigated the active compounds against Leishmania major using activity-guided fractionation. After successive partitioning with nhexane, chloroform, n-butanol and water, the MLC of each layer was measured to be 0.4, 0.2, 6.3 and 200 mg/ml, respectively. Purification of the n-hexane and chloroform layers afforded compounds 1-4 from the n-hexane layer and compounds 1, 3, 5-7 from the chloroform layer. Compounds 1-7 were identified to be dihydrosanguinarine (1), 12) dihydrochelirubine (2), 12) dihydrochelerythrine (3), 12) oxychelerythrine (4), 13) norchelerythrine (5), 14, 15) 12-methoxynorchelerythrine (6) 16) and oxysanguinarine (7), 17) respectively, based on spectral findings (Fig. 1) . This is the first time that these compounds have been isolated from B. pearcei.
The leishmanicidal activities of 1-3 were examined. 4-7 were not examined because the amounts available were insufficient. Among them, dihydrosanguinarine (1) showed the most potent activity (IC 50 : 0.014 mg/ml), and 2 was as effective as 3 (IC 50 : 0.166 mg/ml). To determine the structureactivity relationship of the benzophenanthridine skeleton, we examined the leishmanicidal activities of 32 synthetic samples, including compounds 4 and 5.
Compounds in which the substituents on the A-ring and D-ring were modified were mainly used to examine the structure-activity relationships (Figs. 2, 3) .
As a result, the replacement of a proton by a methoxyl group at C-7 (9 and 16), or the replacement of a hydroxyl by a methoxyl or ethoxyl group at C-8 (24-26; 9 and 12) enhanced the activity. Furthermore, the replacement of a methylenedioxyl by a dimethoxyl group at C-7 and C-8 (19 and 20; 21 and 22; 23 and 24) enhanced the activity. Therefore, bulkiness at C-7 and C-8 apparently contributed to the potent activity. On the other hand, the same bulkiness at C-8 and C-9, or C-2 and C-3 on the D-ring clearly reduced the activity (8 and 9 for C-8 and C-9; 19 and 21, 20 and 22 for C-2 and C-3). A carbonyl group (i.e., oxidation of C-6; 24 and 33; 9 and 27) or substitution at C-6 obviously reduced the activity. The unsaturation of the C-C bond between C-5 and C-6 seemed to be necessary for this activity (30 and 24; 2 and 19). However, several derivatives showed no change in activity (31 and 9; 1 and 23). The methyl group on the nitrogen atom of the C-ring seemed to be important for remarkable activity (24 and 35). Ring-cleavage of the bond between C-5 and C-6 caused a complete loss of activity (36-39). Considering these relationships, the bulkiness on the Aring was thought to help enhance leishmanicidal activity, while bulkiness on the C-ring (17 and 19) and D-ring reduced this activity.
In Vitro Leishmanicidal Activity of Benzophenanthridine Alkaloids from Bocconia pearcei and Related Compounds
Several benzophenanthridine alkaloids including 8 and 9 have been reported to have antimalarial activity (IC 50 1.8 mg/ml for 9; 11.7 mg/ml for 8). If we compare our results to those for antimalarial activity, the effects of bulkiness at C-8 and C-9 for antileishmanial activity are opposite those for antimalarial activity. 18) Interestingly, the structure-activity relationships for leishmanicidal activity were almost the same as those for antitumor activity against the Sarcoma 180 cell line.
19)

Conclusion
We found that several benzophenanthridine compounds had remarkable growth-inhibitory activity against L. major promastigotes in vitro.
B. pearcei has been used as a crude drug, but not for the treatment of leishmania. In this study, we found that methanolic extracts of B. pearcei had significant leishmanicidal activity, and this led us to isolate four benzophenanthridine alkaloids as active constituents.
Benzophenanthridine alkaloids have been reported to have various bioactivities, such as antimicrobial activity, 20) inhibition of tubulin polymerization, 21) suppression of angiogenesis, 22) induction of apoptosis in OCM-1 cells, 23) etc. Benzophenanthridine alkaloids have been reported to have antimalarial activity, but this is the first report of leishmanicidal activity. In some countries, a toothpaste containing sanguinarine is commercially available because sanguinarine inhibits dental plaque and improves gingival health. 24, 25) However, it has been generally difficult to use benzophenanthridine alkaloids as medical products because of their strong toxicity. Although they may be difficult to apply in oral or injectable form, application as an ointment for cutaneous leishmanisis might be a breakthrough for this problem. The effects of these compounds against leishmania amastigotes have not been investigated, and the mechanism of their action toward protozoa will be examined in the near future. 19) were provided by Dr. Tsutomu Ishikawa (Chiba University). General Experimental Procedures HPLC was performed on a Shimadzu LC-10A apparatus with a UV detector (Shimadzu SPD-M10A, Japan). To purify extracts, Silica gel (Merck, Germany), Mega Bond Elut ® (C 18 , Si, Almina) (Varian, U.S.A.), Sephadex LH-20 (GE Healthcare U.K. Ltd., U.K.), and Chromatorex NH-DM1020 (Fuji Silysia Chemical Ltd., Japan) were used.
Cultivation of Leishmania Promastigotes Medium 199 was used for the cultivation of promastigotes of L. major (MHOM/SU/73/5ASKH). Promastigotes were cultured in the medium [supplemented with heat-inactivated (56°C for 30 min) fetal bovine serum (10%)] at 27°C, 5% CO 2 in an incubator.
Leishmanicidal Activity Assay The leishmanicidal effects of each fraction and compound were assessed by the improved 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrasodium bromide (MTT) method described in the previous paper. [8] [9] [10] [11] Amphotericin B was used as a positive control for assay (IC 50 0.04 mg/ml).
Isolation Procedure Air-dried fruits of B. pearcei, Yanali, (498 g) were powdered and extracted with hot methanol (1 lϫ1, 0.6 lϫ2), and the extract was then filtered. The filtrate was concentrated under reduced pressure to yield a residue (65 g), 21 g of which were suspended in 10% methanol/water and then partitioned successively with n-hexane, chloroform and n-butanol. Each layer was evaporated under reduced pressure to afford an n-hexane fraction (Fr. H) (4.0 g), chloroform fraction (Fr. C) (2.6 g), n-butanol fraction (Fr. B) (8.9 g) and water fraction (Fr. W) (3.5 g). Half of Fr. H (2.0 g) was subjected to column chromatography on silica gel with n-hexane/ethylacetate as an eluent to give 32 fractions (Fr. H1-H32). Fr. H7-H9 (eluted with n-hexane/ethylacetateϭ15 : 1) were combined and purified by Bond elut C 18 ® while eluting with acetonitrile/chloroform to give 1 (12 mg). Fr. H10-H15 (eluted with n-hexane/ethylacetateϭ10 : 1) were combined and fractionated by silica gel column chromatography while eluting with a chloroform-ethylacetate-methanol solvent system. Fractions eluted with chloroform were combined and rechromatographed on LH-20 using chloroform/methanol (1 : 1) as an eluent to give 20 fractions. Concentrated fractions 13 and 14 (10 mg) were purified by Bond elut Alumina ® eluted with nhexane-ethylacetate to obtain 2 (2 mg) as colorless needles. Fr. H16-H22 (eluted with n-hexane/EtOAcϭ5 : 1) were purified by Bond elut C 18 ® eluted with acetonitrile-methanol to give 3 (6 mg) as needle crystals. Fr. 3 of this column was purified again by Bond elut C 18 ® eluted with acetonitrile/water to give linoleic acid (43 mg), and HPLC purification of fr. 12 using an ODS column (mobile phase: methanol-water solvent system) gave 4 (1 mg).
Part of Fr. C (1.2 g) was subjected to HPLC on a NH 2 -silica gel column using an n-hexane-chloroform solvent system as a mobile phase to give 48 fractions (Fr. C1-C48). Fr. C13-C16 were combined and concentrated to afford 1 (11 mg). Fr. C23-C28 (eluted with n-hexane/chloroformϭ4 : 1) were combined and rechromatographed on a NH 2 -silica gel column while eluting with an n-hexane-chloroform system to give 48 fractions. 3 (11 mg) was obtained from Fr. 11. Fr. 16 was further purified by HPLC using NH 2 -silica gel (n-hexane/chloroformϭ7 : 2) to give 5 (2 mg) and 6 (1 mg). Fr. C29-C38 (eluted with n-hexane/chloroformϭ75 : 25) were combined and rechromatographed on a silica gel column eluted with n-hexane/ethylacetate to give 7 (2 mg).
1-3, 12) 4-5, [13] [14] [15] 6, 16) 7 7) were characterized by comparison of their respective spectroscopic properties with values in the literature.
